论文部分内容阅读
近10多年来,国内外陆续报道输注胎肝细胞(FLC)治疗急性白血病和再生障碍性贫血等血液性疾病,取得了良好的治疗效果。为了观察FLC对化(放)疗后血细胞的作用,我们对60例晚期妇癌患者在血细胞抑制时分别输注FLC、血液进行治疗。现将结果报道如下。资料与方法一、病人来源及治疗方式:1987年12月至1989年3月在我院住院治疗的晚期妇癌60例,分为两组。在化(放)疗期间血细胞抑制时,一组输注FLC治疗,另一组输血治疗。两组病种及治疗方式见表1。
In the recent 10 years, many domestic and foreign reports of transfusion of fetal liver cells (FLC) treatment of acute leukemia and aplastic anemia and other blood diseases, and achieved good therapeutic effect. In order to observe the effects of FLC on blood cells after chemoradiotherapy, we treated 60 patients with advanced cancer with FLC and blood transfusion respectively during hematocrit suppression. The results are reported below. Materials and methods First, the source of patients and treatment: 60 cases of advanced cancer hospitalized in our hospital from December 1987 to March 1989 were divided into two groups. One group was infused with FLC and the other was transfused when hematocrit was suppressed during chemotherapy. Two groups of diseases and treatment in Table 1.